Self-organized nanoparticles based on chitosan-folic acid and dextran succinate-doxorubicin conjugates for drug targeting

Archives of Pharmacal Research

Volumn 37, Issue 12, 2014, Pages 1546-1553

  Lee, Kyung Dong ^a   Choi, Seon Hee ^b   Kim, Da Hye ^c   Lee, Hye Young ^d   Choi, Ki Choon ^e  

^a Dongshin University   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

^c SHIMANE UNIVERSITY   (Japan)

^d Yeonsung University   (South Korea)

^e National Institute of Animal Science   (South Korea)

Author keywords

Chitosan; Dextran succinate; Folic acid; Nanoparticle; Polyelectrolyte complex

Indexed keywords

CARBOXYLIC ACID; CHITOSAN; DOXORUBICIN; FOLATE RECEPTOR; FOLIC ACID; NANOPARTICLE; SUCCINIC ACID; SUCCINIC ANHYDRIDE; ANTINEOPLASTIC ANTIBIOTIC; DEXTRAN; DRUG CARRIER; FOLATE TRANSPORTER;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL CULTURE; CELL VIABILITY; CONJUGATE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TARGETING; ENDOCYTOSIS; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR VOLUME; TUMOR XENOGRAFT; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; DRUG SCREENING; KB CELL LINE; METABOLISM; NUDE MOUSE; PARTICLE SIZE; SYNTHESIS;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CHITOSAN; DEXTRANS; DOXORUBICIN; DRUG CARRIERS; FEMALE; FOLIC ACID; FOLIC ACID TRANSPORTERS; HUMANS; KB CELLS; MICE, NUDE; NANOPARTICLES; PARTICLE SIZE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84921938862     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-014-0489-z     Document Type: Article

References (23)

1. Akiyoshi, K., S. Kobayashi, S. Shichibe, D. Mix, M. Baudys, S.W. Kim, and J. Sunamoto. 1998. Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: complexation and stabilization of insulin. Journal of Controlled Release 54: 313-320.
2. Bowman, K., and K.W. Leong. 2006. Chitosan nanoparticles for oral drug and gene delivery. International journal of nanomedicine 1: 117-128.
3. Cabral, H., Y. Matsumoto, K. Mizuno, Q. Chen, M. Murakami, M. Kimura, Y. Terada, M.R. Kano, K. Miyazono, M. Uesaka, N. Nishiyama, and K. Kataoka. 2011. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nature Nanotechnology 6: 815-823.
4. Cadée, J.A., M.J. van Luyn, L.A. Brouwer, J.A. Plantinga, P.B. van Wachem, C.J. de Groot, W. den Otter, and W.E. Hennink. 2000. In vivo biocompatibility of dextran-based hydrogels. Journal of Biomedical Materials Research 50: 397-404.
5. Dosio, F., P. Milla, and L. Cattel. 2010. EC-145, a folate-targeted Vinca alkaloid conjugate for the potential treatment of folate receptor-expressing cancers. Current Opinion in Investigational Drugs 11: 1424-1433.
6. Gref, R., Y. Minamitake, M.T. Peracchia, V. Trubetskoy, V. Torchilin, and R. Langer. 1994. Biodegradable long-circulating polymeric nanospheres. Science 263: 1600-1603.
7. Ichinose, K., N. Tomiyama, M. Nakashima, Y. Ohya, M. Ichikawa, T. Ouchi, and T. Kanematsu. 2000. Antitumor activity of dextran derivatives immobilizing platinum complex (II). Anti-Cancer Drugs 11: 33-38.
8. Janes, K.A., P. Calvo, and M.J. Alonso. 2001. Polysaccharide colloidal particles as delivery systems for macromolecules. Advanced Drug Delivery Reviews 47: 83-97.
9. Jeong, Y.I., S.T. Kim, S.G. Jin, H.H. Ryu, Y.H. Jin, T.Y. Jung, I.Y. Kim, and S. Jung. 2008. Cisplatin-incorporated hyaluronic acid nanoparticles based on ion-complex formation. Journal of Pharmaceutical Sciences 97: 1268-1276.
10. Jeong, Y.I., S.G. Jin, I.Y. Kim, J. Pei, M. Wen, T.Y. Jung, K.S. Moon, and S. Jung. 2010. Doxorubicin-incorporated nanoparticles composed of poly(ethylene glycol)-grafted carboxymethyl chitosan and antitumor activity against glioma cells in vitro. Colloids Surfaces B Biointerfaces 79: 149-155.
11. Jeong, Y.I., D.H. Kim, C.W. Chung, J.J. Yoo, K.H. Choi, C.H. Kim, S.H. Ha, and D.H. Kang. 2012. Self-assembled nanoparticles of hyaluronic acid/poly(DL-lactide-co-glycolide) block copolymer. Colloids Surfaces B Biointerfaces 90: 28-35.
12. Jeong, Y.I., K.D. Chung, D.H. Kim, Y.H. Kim, Y.S. Lee, and K.C. Choi. 2013. All-trans retinoic acid-incorporated nanoparticles of deoxycholic acid-conjugated dextran for treatment of CT26 colorectal carcinoma cells. International Journal of Nanomedicine 8: 485-493.
13. Jeong, Y.I., S.H. Kim, T.Y. Jung, I.Y. Kim, S.S. Kang, Y.H. Jin, H.H. Ryu, H.S. Sun, S. Jin, K.K. Kim, K.Y. Ahn, and S. Jung. 2006. Polyion complex micelles composed of all-trans retinoic acid and poly (ethylene glycol)-grafted-chitosan. Journal of Pharmaceutical Sciences 95: 2348-2360.
14. Kumar, M., G. Singh, V. Arora, S. Mewar, U. Sharma, N.R. Jagannathan, S. Sapra, A.K. Dinda, S. Kharbanda, and H. Singh. 2012. Cellular interaction of folic acid conjugated superparamagnetic iron oxide nanoparticles and its use as contrast agent for targeted magnetic imaging of tumor cells. International Journal of Nanomedicine 7: 3503-3516.
15. Lee, H.Y., Y.I. Jeong, and K.C. Choi. 2011. Hair dye-incorporated poly-γ-glutamic acid/glycol chitosan nanoparticles based on ion-complex formation. International Journal Nanomedicine 6: 2879-2888.
16. Lim, S.H., Y.I. Jeong, K.S. Moon, H.H. Ryu, Y.H. Jin, S.G. Jin, T.Y. Jung, I.Y. Kim, S.S. Kang, and S. Jung. 2010. Anticancer activity of PEGylated matrix metalloproteinase cleavable peptide-conjugated adriamycin against malignant glioma cells. International Journal of Pharmaceutics 387: 209-214.
17. Liu, X., W. Cui, B. Li, and Z. Hong. 2012. Targeted therapy for glioma using cyclic RGD-entrapped polyionic complex nanomicelles. International Journal of Nanomedicine 7: 2853-2862.
18. Mbakidi, J.P., N. Drogat, R. Granet, T.S. Ouk, M.H. Ratinaud, E. Rivière, M. Verdier, and V. Sol. 2013. Hydrophilic chlorin-conjugated magnetic nanoparticles-potential anticancer agent for the treatment of melanoma by PDT. Bioorganic & Medicinal Chemistry Letters 23: 2486-2490.
19. Modi, S., J. Prakash Jain, A.J. Domb, and N. Kumar. 2006. Exploiting EPR in polymer drug conjugate delivery for tumor targeting. Current Pharmaceutical Design 12: 4785-4796.
20. Saito, S., M. Tsugeno, D. Koto, Y. Mori, Y. Yoshioka, S. Nohara, and K. Murase. 2012. Impact of surface coating and particle size on the uptake of small and ultrasmall superparamagnetic iron oxide nanoparticles by macrophages. International Journal of Nanomedicine 7: 5415-5421.
21. Wang, W., F. Zhou, L. Ge, X. Liu, and F. Kong. 2012. Transferrin-PEG-PE modified dexamethasone conjugated cationic lipid carrier mediated gene delivery system for tumor-targeted transfection. International Journal of Nanomedicine 7: 2513-2522.
22. Zhou, X., M. Zhang, B. Yung, H. Li, C. Zhou, L.J. Lee, and R.J. Lee. 2012. Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma. International Journal of Nanomedicine 7: 5465-5474.
23. Zwicke GL, Mansoori GA, Jeffery CJ. 2012. Utilizing the folate receptor for active targeting of cancer nanotherapeutics. Nano Reviews 3.